Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE178427 | GEO | 2023/06/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Cytoscan]

Project description:T-cell lymphoblastic lymphoma T-LBL is a rare aggressive neoplasm of precursor T cells whose pathogenesis is not fully elucidated and it is closely related to acute lymphoblastic leukemia (T-ALL), the most common subtype of cancer in children, although recent studies suggest biological differences between the two entities.

2023-06-05 | GSE178421 | GEO

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Oncoscan]

2023-06-05 | GSE178426 | GEO

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma

Project description:Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma

| PRJNA738940 | ENA

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Cytoscan]

Project description:Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Cytoscan]

| PRJNA738942 | ENA

Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Oncoscan]

Project description:Global genetic profiling of a pediatric series of T-cell lymphoblastic lymphoma [Oncoscan]

| PRJNA738941 | ENA

Overlap Between Pediatric Nodal Marginal Zone Lymphoma (PNMZL) and Pediatric-Type Follicular Lymphoma (PTFL) : Morphological and Molecular Analysis

Project description:This SuperSeries is composed of the SubSeries listed below.

2022-07-11 | GSE154834 | GEO

Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia.

Project description:Epigenetic dysregulation is an emerging hallmark of cancers. We developed a high-information-content mass spectrometry approach to profile global histone modifications in human cancers. When applied to 115 lines from the Cancer Cell Line Encyclopedia, this approach identified distinct molecular chromatin signatures. One signature was characterized by increased histone 3 lysine 36 (H3K36) dimethylation, exhibited by several lines harboring translocations in NSD2, which encodes a methyltransferase. A previously unknown NSD2 p.Glu1099Lys (p.E1099K) variant was identified in nontranslocated acute lymphoblastic leukemia (ALL) cell lines sharing this signature. Ectopic expression of the variant induced a chromatin signature characteristic of NSD2 hyperactivation and promoted transformation. NSD2 knockdown selectively inhibited the proliferation of NSD2-mutant lines and impaired the in vivo growth of an NSD2-mutant ALL xenograft. Sequencing analysis of >1,000 pediatric cancer genomes identified the NSD2 p.E1099K alteration in 14% of t(12;21) ETV6-RUNX1-containing ALLs. These findings identify NSD2 as a potential therapeutic target for pediatric ALL and provide a general framework for the functional annotation of cancer epigenomes.

| S-EPMC4262138 | biostudies-literature